Despite the absence of solid scientific evidence supporting the cost-effectiveness of post-transplant surveillance for HCC recurrence, there is broad agreement that periodic contrast imaging with CT or MRI should be performed in the post-LT setting and that periodic AFP should be obtained, particularly in subjects with high AFP values before LT. Here, AFP is linked to hepatocellular carcinoma.